Company / Income Tax per Share
Protagonist Therapeutics, Inc. Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.01
FY2025
5-year range
$0.00 / $0.06
FY2021-FY2025
Trend
-79.7%
vs FY2024
Sector context
#71 of 201
Health Care
What the data says
At $0.01, Protagonist Therapeutics, Inc.'s income tax per share ranks #131 of 201 in the Health Care sector. Income Tax per Share has fluctuated over the past 10 years, ranging from $-0.04 in FY2018 to $0.06 in FY2024.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -19.1%.
Increased from $0.00 to $0.01 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -19.1%
- 10-Year CAGR
- -
Sector benchmark
#131 of 201 in Health CareTop 65% of 201This company $0.01 Sector average $1.35
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 79.7% year-over-year.
- Ranks #71 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2024.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -79.7% |
| FY2024 | $0.06 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | -100.0% |
| FY2020 | $0.04 | +242.2% |
| FY2019 | -$0.03 | +25.3% |
| FY2018 | -$0.04 | - |
| FY2017 | $0.00 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026